Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Suzuki, H."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 37
Tytuł:
Development of rice bran-derived nanoparticles with excellent anti-cancer activity and their application for peritoneal dissemination.
Autorzy:
Sasaki D; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamazaki, Noda, Chiba, 2641, 278-8510, Japan.
Suzuki H; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamazaki, Noda, Chiba, 2641, 278-8510, Japan.
Kusamori K; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamazaki, Noda, Chiba, 2641, 278-8510, Japan.; Laboratory of Cellular Drug Discovery and Development, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamazaki, Noda, Chiba, 2641, 278-8510, Japan.
Itakura S; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamazaki, Noda, Chiba, 2641, 278-8510, Japan.
Todo H; Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado, Saitama, 350-0295, Japan.
Nishikawa M; Laboratory of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamazaki, Noda, Chiba, 2641, 278-8510, Japan. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Mar 16; Vol. 22 (1), pp. 114. Date of Electronic Publication: 2024 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Oryza*
Adenocarcinoma*
Colonic Neoplasms*/drug therapy
Antineoplastic Agents*/pharmacology
Animals ; Mice ; Antioxidants/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Differential expression of microRNAs in colorectal cancer: Different patterns between isolated cancer gland and stromal cells.
Autorzy:
Sato A; Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, Iwate Prefecture, Japan.
Fujita Y; Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, Iwate Prefecture, Japan.
Otsuka K; Department of Surgery, Iwate Medical University, Iwate Prefecture, Japan.
Sasaki A; Department of Surgery, Iwate Medical University, Iwate Prefecture, Japan.
Suzuki H; Department of Molecular Biology, Sapporo Medical University School of Medicine, Hokkaido, Japan.
Matsumoto T; Division of Gastroenterology, Department of Internal Medicine, Iwate Medical University, Iwate Prefecture, Japan.
Sugai T; Department of Molecular Diagnostic Pathology, School of Medicine, Iwate Medical University, Iwate Prefecture, Japan.
Pokaż więcej
Źródło:
Pathology international [Pathol Int] 2020 Jan; Vol. 70 (1), pp. 21-30. Date of Electronic Publication: 2019 Nov 21.
Typ publikacji:
Journal Article
MeSH Terms:
Transcriptome*
Tumor Microenvironment*
Adenocarcinoma/*pathology
Colorectal Neoplasms/*pathology
MicroRNAs/*biosynthesis
Adenocarcinoma/genetics ; Aged ; Aged, 80 and over ; Colorectal Neoplasms/genetics ; Female ; Humans ; Male ; MicroRNAs/analysis ; Middle Aged ; Stromal Cells/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Short-term outcomes of multicenter prospective cohort study of gastric endoscopic resection: 'Real-world evidence' in Japan.
Autorzy:
Suzuki H; Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Takizawa K; Division of Endoscopy, Shizuoka Cancer Center, Sunto-gun, Osaka, Japan.
Hirasawa T; Department of Gastroenterology, Cancer Institute Hospital, Tokyo, Japan.
Takeuchi Y; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
Ishido K; Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
Hoteya S; Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
Yano T; Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan.
Tanaka S; Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan.
Endo M; Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Morioka, Japan.
Nakagawa M; Department of Endoscopy, Hiroshima City Hospital, Hiroshima, Japan.
Toyonaga T; Department of Endoscopy, Kobe University Hospital, Kobe, Japan.
Doyama H; Department of Gastroenterology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Hirasawa K; Division of Endoscopy, Yokohama City University Medical Center, Yokohama, Japan.
Matsuda M; Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan.
Yamamoto H; Division of Gastroenterology, Department of Internal Medicine, Jichi Medical University, Shimotsuke, Japan.
Fujishiro M; Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Hashimoto S; Division of Gastroenterology and Hepatology, Niigata University Medical and Dental Hospital, Niigata, Japan.
Maeda Y; Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Japan.
Oyama T; Department of Endoscopy, Saku Central Hospital Advanced Care Center, Saku, Japan.
Takenaka R; Department of Gastroenterology, Tsuyama Chuo Hospital, Tsuyama, Japan.
Yamamoto Y; Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan.
Naito Y; Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Michida T; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Kobayashi N; Department of Gastroenterology, Tochigi Cancer Center, Utsunomiya, Japan.
Kawahara Y; Department of Endoscopy, Okayama University Hospital, Okayama, Japan.
Hirano M; Department of Internal Medicine, Niigata Prefectural Central Hospital, Joetsu, Japan.
Jin M; Department of Gastroenterology, Akita University Graduate School of Medicine, Akita, Japan.
Hori S; Department of Gastroenterology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Niwa Y; Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan.
Hikichi T; Department of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
Shimazu T; Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.
Ono H; Division of Endoscopy, Shizuoka Cancer Center, Sunto-gun, Osaka, Japan.
Tanabe S; Department of Advanced Medicine, Research and Development Center for New Medical Frontiers, Kitasato University, Sagamihara, Japan.
Kondo H; Center for Digestive Diseases Tonan Hospital, Sapporo, Japan.
Iishi H; Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
Ninomiya M; Digestive Disease Center, Hiroshima Memorial Hospital, Hiroshima, Japan.
Pokaż więcej
Corporate Authors:
Ichiro Oda for J-WEB/EGC group; Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Źródło:
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society [Dig Endosc] 2019 Jan; Vol. 31 (1), pp. 30-39. Date of Electronic Publication: 2018 Sep 25.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Endoscopic Mucosal Resection*
Adenocarcinoma/*surgery
Stomach Neoplasms/*surgery
Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Humans ; Japan ; Male ; Middle Aged ; Stomach Neoplasms/pathology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Afatinib successfully treated leptomeningeal metastasis during erlotinib treatment in a patient with EGFR-mutant (Exon18:G719S) lung adenocarcinoma as a second-line chemotherapy.
Autorzy:
Tamiya M; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Shiroyama T; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Nishihara T; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Nishida T; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Hayama M; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Tanaka A; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Morishita N; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Suzuki H; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Okamoto N; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Hirashima T; Department of Thoracic Malignancy, Osaka Prefectural Hospital Organization Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Habikino City, Osaka, Japan.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2017 Oct; Vol. 13 (5), pp. e531-e533. Date of Electronic Publication: 2016 Dec 22.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma/*drug therapy
ErbB Receptors/*antagonists & inhibitors
Erlotinib Hydrochloride/*therapeutic use
Lung Neoplasms/*drug therapy
Quinazolines/*therapeutic use
Radiation-Sensitizing Agents/*therapeutic use
Adenocarcinoma/pathology ; Adenocarcinoma of Lung ; Afatinib ; Aged ; Carcinoma, Non-Small-Cell Lung/pathology ; Erlotinib Hydrochloride/administration & dosage ; Erlotinib Hydrochloride/pharmacology ; Female ; Humans ; Lung Neoplasms/pathology ; Mutation ; Quinazolines/administration & dosage ; Quinazolines/pharmacology ; Radiation-Sensitizing Agents/administration & dosage ; Radiation-Sensitizing Agents/pharmacology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer.
Autorzy:
Higuchi M; Department of Chest Surgery, School of Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima, 960-1295, Japan. .
Owada Y; Department of Chest Surgery, School of Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima, 960-1295, Japan.
Inoue T; Department of Chest Surgery, School of Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima, 960-1295, Japan.
Watanabe Y; Department of Chest Surgery, School of Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima, 960-1295, Japan.
Yamaura T; Department of Chest Surgery, School of Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima, 960-1295, Japan.
Fukuhara M; Department of Chest Surgery, School of Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima, 960-1295, Japan.
Hasegawa T; Department of Chest Surgery, School of Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima, 960-1295, Japan.
Suzuki H; Department of Chest Surgery, School of Medicine, Fukushima Medical University, 1-Hikarigaoka, Fukushima, 960-1295, Japan.
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2016 Sep 05; Vol. 14 (1), pp. 238. Date of Electronic Publication: 2016 Sep 05.
Typ publikacji:
Case Reports; Evaluation Study; Journal Article
MeSH Terms:
Positron-Emission Tomography*
Adenocarcinoma/*drug therapy
Antibodies, Monoclonal/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Monitoring, Physiologic/*instrumentation
Neoplasm Recurrence, Local/*diagnostic imaging
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/pathology ; Adenocarcinoma/surgery ; Adenocarcinoma of Lung ; Aged ; Antibodies, Monoclonal/administration & dosage ; Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoembryonic Antigen/blood ; Carcinoma, Non-Small-Cell Lung/diagnostic imaging ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/surgery ; Cisplatin/therapeutic use ; Fluorodeoxyglucose F18/administration & dosage ; Fluorodeoxyglucose F18/pharmacokinetics ; Humans ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/pathology ; Lung Neoplasms/surgery ; Male ; Neoplasm Grading ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Staging ; Neutrophil Infiltration/drug effects ; Nivolumab ; Pemetrexed/therapeutic use ; Pneumonectomy ; Radiopharmaceuticals/administration & dosage ; Radiopharmaceuticals/pharmacokinetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Ground-glass nodule in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK)-positive lung cancer: a case report.
Autorzy:
Owada Y; Department of Thoracic Surgery, Takeda General Hospital, Fukushima, Japan.; Department of Regenerative Surgery, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Yonechi A; Department of Thoracic Surgery, Takeda General Hospital, Fukushima, Japan.; Department of Regenerative Surgery, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Higuchi M; Department of Regenerative Surgery, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Suzuki H; Department of Regenerative Surgery, School of Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2016 Mar 10; Vol. 14, pp. 81. Date of Electronic Publication: 2016 Mar 10.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma/*pathology
Lung Neoplasms/*pathology
Oncogene Proteins, Fusion/*genetics
Adenocarcinoma/genetics ; Female ; Humans ; In Situ Hybridization, Fluorescence ; Lung Neoplasms/genetics ; Middle Aged ; Prognosis ; Tomography, X-Ray Computed
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Cytokeratin 7-positive/cytokeratin 20-negative cecal adenocarcinoma metastatic to the uterine cervix: a case report.
Autorzy:
Toyoshima M; Department of Obstetrics and Gynecology, Sendai Medical Center, National Hospital Organization, Sendai, Japan. .; Present address: Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, 2-8-8, Miyagino, Miyagino-ku, Sendai, Miyagi, 983-8520, Japan. .
Momono Y; Department of Obstetrics and Gynecology, Sendai Medical Center, National Hospital Organization, Sendai, Japan. my_.
Makino H; Department of Obstetrics and Gynecology, Sendai Medical Center, National Hospital Organization, Sendai, Japan. .
Kudo T; Department of Obstetrics and Gynecology, Sendai Medical Center, National Hospital Organization, Sendai, Japan. .
Oka N; Department of Pathology, Sendai Medical Center, National Hospital Organization, Sendai, Japan. .
Sakurada J; Department of Pathology, Sendai Medical Center, National Hospital Organization, Sendai, Japan. .
Suzuki H; Department of Pathology, Sendai Medical Center, National Hospital Organization, Sendai, Japan. .
Kodama H; Department of Surgery, Sendai Medical Center, National Hospital Organization, Sendai, Japan. .
Yoshinaga K; Department of Obstetrics and Gynecology, Sendai Medical Center, National Hospital Organization, Sendai, Japan. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2016 Jan 25; Vol. 14 (1), pp. 22. Date of Electronic Publication: 2016 Jan 25.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma/*pathology
Cecal Neoplasms/*pathology
Keratin-20/*metabolism
Keratin-7/*metabolism
Neoplasms, Second Primary/*pathology
Uterine Cervical Neoplasms/*secondary
Adenocarcinoma/metabolism ; Adenocarcinoma/surgery ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biomarkers, Tumor/metabolism ; Cecal Neoplasms/metabolism ; Cecal Neoplasms/surgery ; Female ; Humans ; Immunoenzyme Techniques ; Middle Aged ; Neoplasm Staging ; Neoplasms, Second Primary/drug therapy ; Neoplasms, Second Primary/metabolism ; Prognosis ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum.
Autorzy:
Matsubara A; Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Ogawa R; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Suzuki H; Endoscopy Division, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Oda I; Endoscopy Division, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Taniguchi H; Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Kanai Y; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Kushima R; Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Sekine S; 1] Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo 104-0045, Japan [2] Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2015 Apr 14; Vol. 112 (8), pp. 1398-404. Date of Electronic Publication: 2015 Mar 24.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma/*genetics
Duodenal Neoplasms/*genetics
GTP-Binding Protein alpha Subunits, Gs/*genetics
Proto-Oncogene Proteins/*genetics
Stomach Diseases/*pathology
ras Proteins/*genetics
Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Chromogranins ; Duodenal Neoplasms/pathology ; Humans ; Middle Aged ; Mutation ; Proto-Oncogene Proteins p21(ras) ; Sequence Analysis, DNA ; Stomach Diseases/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks.
Autorzy:
Nomiya T; Department of Radiation Oncology, National Institute of Radiological Sciences, Chiba, Japan.
Tsuji H; Department of Radiation Oncology, National Institute of Radiological Sciences, Chiba, Japan.
Maruyama K; Department of Radiation Oncology, National Institute of Radiological Sciences, Chiba, Japan.
Toyama S; Department of Radiation Oncology, National Institute of Radiological Sciences, Chiba, Japan.
Suzuki H; Department of Urology, Toho University School of Medicine, Chiba, Japan.
Akakura K; Department of Urology, Tokyo Koseinenkin Hospital, Tokyo, Japan.
Shimazaki J; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nemoto K; Department of Radiation Oncology, Yamagata University School of Medicine, Yamagata, Japan.
Kamada T; Department of Radiation Oncology, National Institute of Radiological Sciences, Chiba, Japan.
Tsujii H; Department of Radiation Oncology, National Institute of Radiological Sciences, Chiba, Japan.
Pokaż więcej
Corporate Authors:
Working Group for Genitourinary Tumors
Źródło:
British journal of cancer [Br J Cancer] 2014 May 13; Vol. 110 (10), pp. 2389-95. Date of Electronic Publication: 2014 Apr 10.
Typ publikacji:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Heavy Ion Radiotherapy*/adverse effects
Adenocarcinoma/*radiotherapy
Carbon/*therapeutic use
Prostatic Neoplasms/*radiotherapy
Adenocarcinoma/drug therapy ; Aged ; Aged, 80 and over ; Androgen Antagonists/therapeutic use ; Antineoplastic Agents, Hormonal/therapeutic use ; Carbon/adverse effects ; Combined Modality Therapy ; Disease-Free Survival ; Dose Fractionation, Radiation ; Follow-Up Studies ; Gastrointestinal Hemorrhage/epidemiology ; Gastrointestinal Hemorrhage/etiology ; Heavy Ions/adverse effects ; Hematuria/epidemiology ; Hematuria/etiology ; Humans ; Incidence ; Male ; Middle Aged ; Organs at Risk ; Prostatic Neoplasms/drug therapy ; Radiation Injuries/epidemiology ; Radiation Injuries/etiology ; Radiotherapy Planning, Computer-Assisted ; Rectum/radiation effects ; Treatment Outcome ; Urinary Bladder/radiation effects ; Urination Disorders/epidemiology ; Urination Disorders/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence.
Autorzy:
Hirata K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Tokyo, Japan.
Suzuki H
Imaeda H
Matsuzaki J
Tsugawa H
Nagano O
Asakura K
Saya H
Hibi T
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2013 Jul 23; Vol. 109 (2), pp. 379-86. Date of Electronic Publication: 2013 Jun 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*/metabolism
Adenocarcinoma/*diagnosis
Hyaluronan Receptors/*physiology
Neoplasm Recurrence, Local/*diagnosis
Stomach Neoplasms/*diagnosis
Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Adenocarcinoma/surgery ; Aged ; Aged, 80 and over ; Disease Progression ; Endoscopy ; Female ; Gastrectomy/methods ; Humans ; Hyaluronan Receptors/metabolism ; Male ; Middle Aged ; Prognosis ; Stomach Neoplasms/metabolism ; Stomach Neoplasms/pathology ; Stomach Neoplasms/surgery ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Adenocarcinoma of the minor duodenal papilla: report of a case.
Autorzy:
Hoshino A; Institute of Gastroenterology, Nippon Medical School Musashi Kosugi Hospital, Kawasaki, Kanagawa, Japan. />Nakamura Y
Suzuki H
Mizutani S
Ishii H
Watanabe M
Bou H
Yoshino M
Komine O
Uchida E
Pokaż więcej
Źródło:
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2013; Vol. 80 (2), pp. 165-70.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma/*pathology
Duodenal Neoplasms/*pathology
Pancreatic Ducts/*pathology
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/surgery ; Cell Differentiation ; Duodenal Neoplasms/diagnostic imaging ; Duodenal Neoplasms/surgery ; Duodenoscopy ; Endoscopy ; Female ; Humans ; Middle Aged ; Pancreatic Ducts/diagnostic imaging ; Pancreatic Ducts/surgery ; Radiography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neuroendocrine differentiation in stage D2 prostate cancers.
Autorzy:
Kamiya N; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Suzuki H
Kawamura K
Imamoto T
Naya Y
Tochigi N
Kakuta Y
Yamaguchi K
Ishikura H
Ichikawa T
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2008 May; Vol. 15 (5), pp. 423-8.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma/*blood
Adenocarcinoma/*pathology
Chromogranin A/*blood
Phosphopyruvate Hydratase/*blood
Prostatic Neoplasms/*blood
Prostatic Neoplasms/*pathology
Aged ; Aged, 80 and over ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Neoplasm Staging ; Neurosecretory Systems/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Genetic changes in pT2 and pT3 prostate cancer detected by comparative genomic hybridization.
Autorzy:
Fukasawa S; Department of Urology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kino M
Kobayashi M
Suzuki H
Komiya A
Imamoto T
Hirokawa Y
Shiraishi T
Takiguchi M
Ishida H
Shindo T
Seki N
Ichikawa T
Pokaż więcej
Źródło:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2008; Vol. 11 (3), pp. 303-10. Date of Electronic Publication: 2007 Oct 09.
Typ publikacji:
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma/*genetics
Adenocarcinoma/*pathology
Cytogenetic Analysis/*methods
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*pathology
Aged ; Chromosome Aberrations ; Chromosomes, Human, Pair 13 ; Chromosomes, Human, Pair 8 ; Gene Deletion ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Nucleic Acid Hybridization/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Treatment and prognosis of patients with paraplegia or quadriplegia because of metastatic spinal cord compression in prostate cancer.
Autorzy:
Nagata M; Department of Urology, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Ueda T
Komiya A
Suzuki H
Akakura K
Ishihara M
Tobe T
Ichikawa T
Igarashi T
Ito H
Pokaż więcej
Źródło:
Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2003; Vol. 6 (2), pp. 169-73.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma/*complications
Adenocarcinoma/*secondary
Bone Neoplasms/*complications
Bone Neoplasms/*secondary
Carcinoma, Squamous Cell/*complications
Carcinoma, Squamous Cell/*secondary
Paraplegia/*etiology
Paraplegia/*rehabilitation
Prostatic Neoplasms/*pathology
Quadriplegia/*etiology
Quadriplegia/*rehabilitation
Spinal Cord Compression/*complications
Spinal Cord Compression/*etiology
Aged ; Aged, 80 and over ; Androgen Antagonists/therapeutic use ; Decompression, Surgical ; Humans ; Laminectomy ; Male ; Middle Aged ; Paraplegia/therapy ; Prognosis ; Quadriplegia/therapy ; Recurrence ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Adenocarcinoma arising from the prostatic duct mimicking transitional cell carcinoma.
Autorzy:
Ohyama C; Department of Urology, Sendai National Hospital, Sendai, Japan. />Takyu S
Yoshikawa K
Suzuki H
Tezuka F
Hasuda A
Inaba Y
Hoshi S
Orikasa S
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2001 Jul; Vol. 8 (7), pp. 408-11.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma/*pathology
Carcinoma, Transitional Cell/*pathology
Prostatic Neoplasms/*pathology
Adenocarcinoma/diagnostic imaging ; Aged ; Carcinoma, Transitional Cell/diagnostic imaging ; Diagnosis, Differential ; Humans ; Male ; Prostatic Neoplasms/diagnostic imaging ; Ultrasonography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Juxtaglomerular cell tumor without hypertension.
Autorzy:
Hayami S; Department of Urology, Yamagata University, School of Medicine, Japan.
Sasagawa I
Suzuki H
Kubota Y
Nakada T
Endo Y
Pokaż więcej
Źródło:
Scandinavian journal of urology and nephrology [Scand J Urol Nephrol] 1998 May; Vol. 32 (3), pp. 231-3.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Adenocarcinoma/*diagnosis
Kidney Neoplasms/*diagnosis
Adenocarcinoma/pathology ; Adenocarcinoma/surgery ; Diagnostic Imaging ; Humans ; Hypertension/diagnosis ; Hypertension/pathology ; Hypertension/surgery ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Male ; Microscopy, Electron ; Middle Aged ; Renin/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 37

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies